You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《公司業績》國藥(01099.HK)去年純利77.6億元人幣升7.9% 派末期息75分人幣
阿思達克 03-21 08:28
國藥控股(01099.HK)公佈截至去年12月底止全年業績,營業額5,210.51億元人民幣(下同),按年升14.2%。純利77.59億元,按年升7.9%;每股盈利2.49元。派每股末期息75分,上年同期派69分。 期內集團藥品分銷板塊收入佔比按年下降1.56個百分點至72.62%,而醫療器械和藥品零售板塊則分別按年上升1.1個百分點和0.26個百分點,達到20.14%和5.41%。 截至去年底,集團累計開展集中配送和SPD項目分別按年增加103個和92個,其中新增醫聯體、醫共體服務項目達到8個。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account